Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States.
Saved in:
| Title: | Real-World Persistence After Starting Bictegravir- or Dolutegravir-Based Regimens Among Adults Aged ≥50 Years with HIV in the United States. |
|---|---|
| Authors: | Kong, Amanda M.1 (AUTHOR), Lucia, Jacqueline1 (AUTHOR), Christoph, Mary J.2 (AUTHOR), Mordi, Uche2 (AUTHOR), Joseph, Daisha1 (AUTHOR), Askin, Gulce1 (AUTHOR), Yucuma, Daniela3 (AUTHOR), Menezes, Neia Prata2 (AUTHOR), McMahon, Peter2 (AUTHOR), Lim, Travis2 (AUTHOR) travis.lim1@gilead.com |
| Source: | Drugs & Aging. Feb2026, Vol. 43 Issue 2, p175-187. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 1170229X |
|---|---|
| DOI: | 10.1007/s40266-026-01279-9 |
